Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A

NCT02634723 · clinicaltrials.gov ↗

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

BIOLOGICAL: Octocog alfa (recombinant human coagulation factor VIII)

Sponsor

Baxalta now part of Shire